138 related articles for article (PubMed ID: 9209795)
1. Prostatic cancer: hospital-based prostate specific antigen screening.
Vogl M; Müller MM; Höltl W
Clin Biochem; 1997 Jun; 30(4):357-60. PubMed ID: 9209795
[No Abstract] [Full Text] [Related]
2. Prostate-specific antigen and prostate cancer prognosis.
Church TR
J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347
[No Abstract] [Full Text] [Related]
3. Simulated screening for prostate cancer: the useful model.
Church TR
J Natl Cancer Inst; 2003 Jun; 95(12):838-9. PubMed ID: 12813160
[No Abstract] [Full Text] [Related]
4. The cautionary tale of PSA testing.
Hoffman RM; Zeliadt SB
Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
[No Abstract] [Full Text] [Related]
5. Prostate-specific antigen dynamics and prostate cancer diagnosis.
Bartoletti R
Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
[No Abstract] [Full Text] [Related]
6. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
7. Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).
Roobol MJ; Schröder FH; van Leenders GL; Hessels D; van den Bergh RC; Wolters T; van Leeuwen PJ
Eur Urol; 2010 Dec; 58(6):893-9. PubMed ID: 20933321
[TBL] [Abstract][Full Text] [Related]
8. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
9. Lest we abandon digital rectal examination as a screening test for prostate cancer.
Basler JW; Thompson IM
J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
[No Abstract] [Full Text] [Related]
10. Prostate cancer in the serum prostate-specific antigen era.
Humphrey PA
Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595
[No Abstract] [Full Text] [Related]
11. Early detection of prostate cancer. Role of prostate-specific antigen.
Prabhakaran VM
Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
[TBL] [Abstract][Full Text] [Related]
12. Re: Is a screening interval of every 4 years for prostate cancer acceptable?
Roobol MJ; Schröder FH
J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797
[No Abstract] [Full Text] [Related]
13. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
14. Prostate cancer: 4. Screening.
Meyer F; Fradet Y
CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
[No Abstract] [Full Text] [Related]
15. Predictive properties of serum prostate-specific antigen testing in a community setting.
Volk RJ; Spann SJ; Mold JW
Arch Intern Med; 1997 Aug 11-25; 157(15):1765-6. PubMed ID: 9250239
[No Abstract] [Full Text] [Related]
16. Studies of prostate-cancer mortality: caution advised.
Etzioni R; Feuer E
Lancet Oncol; 2008 May; 9(5):407-9. PubMed ID: 18452850
[No Abstract] [Full Text] [Related]
17. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
18. Should routine screening for prostate-specific antigen be recommended?
Oottamasathien S; Crawford ED
Arch Intern Med; 2003 Mar; 163(6):661-2; discussion 666. PubMed ID: 12639195
[No Abstract] [Full Text] [Related]
19. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
20. Prostate cancer: numbers may not tell the whole story.
Reynolds T
J Natl Cancer Inst; 2000 Dec; 92(23):1873-6. PubMed ID: 11106674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
